Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gestational diabetes: definition, screening and management].

I Geronooz1, A J Scheen, J M Foidart

  • 1Département de Médecine, CHU Sart Tilman, Université de Liège.

Revue Medicale De Liege
|July 8, 1999
PubMed
Summary

Gestational diabetes mellitus (GDM) affects 1-4% of pregnancies, presenting as glucose intolerance during pregnancy. Screening methods and adverse effects remain debated, with diet and insulin therapy as treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Public Health

Context:

  • Gestational diabetes mellitus (GDM) affects 1-4% of pregnancies, characterized by glucose intolerance with onset during gestation.
  • The clinical entity of GDM is heterogeneous, with ongoing debate regarding its adverse effects on maternal and fetal health.
  • Controversies persist regarding the necessity of universal screening and the optimal screening methodologies for GDM.

Purpose:

  • To review the definition, prevalence, screening methods, and treatment of gestational diabetes mellitus.
  • To highlight the heterogeneous nature of GDM and the ongoing discussions surrounding its management.
  • To provide an overview of current diagnostic and therapeutic approaches for GDM.

Summary:

  • GDM is defined as glucose intolerance first recognized during pregnancy, affecting 1-4% of pregnant women.

Related Experiment Videos

  • Screening for GDM can be performed using a 50g glucose load test (O'Sullivan test) with confirmation by a 100g oral glucose tolerance test (OGTT), or directly with a 75g OGTT between 24-28 weeks gestation.
  • Treatment primarily involves dietary management, with insulin therapy considered if glycemic control is not achieved.

    • Impact:

    • Informs healthcare providers about current screening and treatment guidelines for GDM.
    • Highlights areas of ongoing research and clinical debate in GDM management.
    • Contributes to the understanding of GDM's impact on maternal and child health outcomes.